Across 4 review studies, all 4 reported beneficial effects of Lactobacillus acidophilus L-92 on allergic symptoms, with effect sizes ranging from small to moderate (predominantly moderate). The evidence is drawn entirely from literature reviews summarizing human clinical trials, but individual study details (doses, durations, sample sizes, statistical significance) are not reported. No specific dose range or population segment could be identified due to missing data.
Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 4 studies) — conclusions should be considered preliminary. All included studies are reviews, not primary clinical trials, which limits the certainty of the findings. None of the studies report statistical significance, effect sizes are qualitative, and no dosing or form information is available.
Lactobacillus acidophilus L-92 has been reported to improve symptoms in patients with atopic dermatitis and allergic rhinitis in human studies.
Lactobacillus acidophilus L-92 has been reported to help prevent and manage gastrointestinal and systemic disorders.
A number of preclinical and clinical studies suggest that these biotics and metabolites have promising health effects...
Lactobacillus acidophilus L-92 has been reported to alleviate symptoms of pollen allergy, atopic dermatitis, and house dust mite allergy in human clinical studies.